REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Provet S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Business Support Services | Diagnostic Imaging Centers
Full name: Laboratorios Provet S.A.S. Profile Updated: June 04, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Laboratorios Provet S.A.S. is an enterprise in Colombia, with the main office in Funza. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on September 28, 1985. It currently has a total number of 75 (2012) employees. The latest financial highlights indicate a net sales revenue increase of 20.71% in 2025. A growth of 8.55% was recorded in its total assets. The net profit margin of Laboratorios Provet S.A.S. increased by 3.14% in 2025.

Headquarters
Aut Medellin Km 7 Par Celta Trade Park P
Funza; Cundinamarca;

Contact Details: Purchase the Laboratorios Provet S.A.S. report to view the information.

Website: http://www.laboratoriosprovet.com

Basic Information
Total Employees:
Purchase the Laboratorios Provet S.A.S. report to view the information.
Registered Capital:
Purchase the Laboratorios Provet S.A.S. report to view the information.
Financial Auditors:
Purchase the Laboratorios Provet S.A.S. report to view the information.
Incorporation Date:
September 28, 1985
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorios Provet S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
20.71%
Total Operating Revenue
21.94%
Operating Profit
45.61%
EBITDA
43.93%
Net Profit/Loss for the Period
37.36%
Total Assets
8.55%
Total Equity
24.47%
Operating Profit Margin
7.09%
Net Profit Margin
3.14%
Return on Equity (ROE)
6.79%
Debt / Equity
-0.01%
Quick Ratio
0.07%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?